Pacira BioSciences Inc. (PCRX)
PCRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$36.31
-0.11% on the day
Market cap
$1.4B
Small cap
Revenue · 2025
$726.4M
+3.6% on 2024
Net income · 2025
$7.0M
1.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PCRX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2011 |
| SEC CIK | 0001396814 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $726.4M |
| Net income | $7.0M |
| Operating income | $19.2M |
| Net margin | 1.0% |
| Operating margin | 2.6% |
| Revenue growth | +3.6% |
| Cash | $158.5M |
| Total assets | $1.3B |
| P/E (computed) | 206.8× |
| P/S (computed) | 2.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2014-04-09 |
| Latest annual report 10-K - PCRX - 12.31.2025 | 10-K | 2026-02-26 |
| Latest quarterly / interim 10-Q - PCRX - 06.30.2026 | 10-Q | 2026-08-04 |
| Latest current report FORM 8-K | 8-K | 2026-10-08 |
| Latest proxy | DEFA14A | 2026-06-04 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +44.5% |
| 1 month | +51.2% |
| 3 months | +42.2% |
| Year to date | +40.7% |
| 1 year | +63.6% |
| From 52-week high | 0.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| STOK | Stoke Therapeutics Inc. | $22.50 | -6.83% | $1.5B |
| KRSA | Korsana Biosciences Inc. | $31.66 | -6.99% | $1.4B |
| RARE | Ultragenyx Pharmaceutical Inc. | $14.92 | -2.48% | $1.5B |
| QURE | uniQure N.V. | $21.28 | -2.56% | $1.5B |
| AAPG | Ascentage Pharma Group International American Depository Shares | $15.06 | -1.63% | $1.4B |
| PAHC | Phibro Animal Health Corporation | $36.81 | -1.66% | $1.5B |
| INVA | Innoviva Inc. | $20.74 | -3.31% | $1.5B |
| KLRA | Kailera Therapeutics Inc. | $10.77 | -4.94% | $1.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier